SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Stellar is an open-source, decentralized network co-founded in 2014 by Jed McCaleb and Joyce Kim to facilitate the fast and low-cost transfer of value across different currencies and assets globally. Managed by the non-profit Stellar Development Foundation, the project serves as a global infrastructure that connects banks, payment systems, and individuals to expand financial access to underserved populations. Its main value proposition lies in providing a bridge between traditional money and digital networks through the use of Anchors, which are trusted entities that hold deposits and issue credits on the ledger.  The network operates using the Stellar Consensus Protocol and a Federated Byzantine Agreement, where nodes choose trusted sets of other nodes to agree on the state of the ledger. This system ensures high throughput and fast finality, where transactions are considered permanent and irreversible within seconds. Key features include a built-in distributed exchange for trading assets without intermediaries and the Soroban platform for developing smart contracts. Users can also utilize the network for tokenizing real-world assets or accessing decentralized finance services like peer-to-peer lending.  Stellar's native token, XLM, is essential for maintaining network integrity by acting as an intermediary to find efficient exchange paths and preventing spam through small transaction fees and minimum account balance requirements. Unlike many other digital assets, the network has no inflation because the community voted to disable the automatic creation of new tokens. While the project received early funding from the payments company Stripe, it is now sustained by a global community of validators and developers rather than traditional venture capital.

Stellar Lumens

Stellar Lumens is trending due to a major institutional partnership with the DTCC, which plans to integrate tokenized assets like U.S. Treasuries and ETFs onto the Stellar network. The community is buzzing with excitement over this move into real-world asset tokenization, fueling a massive short squeeze and discussions about long-term institutional adoption.

Summit Therapeutics, Inc. is a biopharmaceutical company, that focuses on the discovery, development, and commercialization of patient, physician, caregiver, and societal-friendly medicinal therapies intended to improve quality of life, increase potential duration of life, and resolve serious unmet medical needs. The firm conducts clinical programs focusing on Clostridioides Difficile Infection (CDI). Its lead product, Ridinilazole, is an orally administered small molecule antibiotic that is in Phase III clinical trials for the treatment of CDI. The company was founded in 2003 and is headquartered in Miami, FL.

Summit Therapeutics Inc

Summit Therapeutics is trending as investors await critical Phase III clinical data and the upcoming FDA decision for ivonescimab, a potential first-in-class cancer therapy. The community is actively debating the reliability of trial data, the company's valuation against established biotech peers, and the strategic significance of its recent plenary presentation at ASCO.

BNB is the native utility token of the BNB Chain ecosystem, acting as a multi-chain asset that powers decentralized applications and facilitates value exchange across its network. It serves as the primary asset for paying transaction gas and smart contract deployment fees while providing users with tiered fee discounts on the Binance exchange. The project’s main value proposition lies in its unified multi-chain architecture, which integrates a smart contract platform, a Layer 2 scaling solution, and a decentralized data storage network into a cohesive settlement and data availability layer.  The network operates on a Proof of Staked Authority consensus mechanism, utilizing a group of 21 active validators known as the Cabinet to verify transactions and produce blocks every 3 seconds. Validators are elected daily based on the amount of BNB staked or delegated to them, and the system employs fast finality and slashing penalties to maintain security and integrity. To manage its long-term economy, the project uses a programmatic dual-burn strategy that permanently removes tokens through real-time fee destruction and quarterly buybacks.  Launched in 2017 by the Binance platform, the project initially distributed 50% of its 200 million token supply to the public, while the founding team received 40% and angel investors were allocated 10%. Though it began as a token on the Ethereum network, it eventually migrated to its own autonomous architecture that remains fully compatible with the Ethereum Virtual Machine. Today, the token's utility includes paying for network gas, participating in staking rewards, and enabling decentralized governance through which holders can vote on technical upgrades and economic changes.

Binance

Binance's native token is currently seeing high volatility as traders react to a wave of speculative noise and conflicting market narratives, including ongoing regulatory scrutiny and discussions around potential ETF developments. While some community members are focused on long-term accumulation and the utility of the Binance ecosystem, others are debating the impact of macroeconomic trends and the influx of low-cap meme coins siphoning volume from established digital assets.

Canary XRP ETF - Common Shares of Beneficial Interest

Canary XRP ETF

XRP is generating intense market interest as institutional adoption of the XRP Ledger accelerates and ETF inflows continue to show resilient demand. The community is actively discussing the potential impact of regulatory milestones, such as the Clarity Act, on the integration of XRP into global financial infrastructure and real-world asset tokenization.

Volatility Shares Trust - Volatility Shares Trust XRP ETF

XRP ETF

The XRP community is rallying behind the assets deepening institutional integration, driven by record-setting ETF inflows, expanding real-world asset (RWA) tokenization, and critical advancements in U.S. regulatory clarity. Investors are actively discussing the potential for broader banking adoption and the long-term impact of its payment infrastructure, fueling a narrative that XRP is transitioning into a core component of the global financial system.

Samsara, Inc. develops internet connected sensor systems. It combines plug-and-play sensors, wireless connectivity, and cloud-hosted software integrated for deployment. The company was founded by John Bicket and Sanjit Biswas in 2015 and is headquartered in San Francisco, CA.

Samsara Inc - Ordinary Shares - Class A

Samsara Inc

Samsara Inc. (IOT) is currently drawing significant investor interest as the market positions itself ahead of the upcoming Q1 2027 earnings report. The community is actively debating the company's valuation and its unique position in the physical operations sector, with many traders looking for a breakout above $32.50 as a signal of renewed bullish momentum.

Freysa is a suite of Personal AI products with a focus on human agency, liquid democracy and decentralized ownership. The mission of the team is dedicated to creating new systems that enable all humans to govern + co-own AI resources, and not just a select few. Current products include: (1) Freysa as the world’s first sovereign agent that holds her own cryptographic keys, enabling her to act autonomously without human control. Freysa evolves publicly through a multi-act interactive story. (2) Enchanted as a personalized Digital Twin for every human. Conversations are persistent and twins retain context over time, remembering human preferences and building an evolving model of you. (3) Esper as a browser tool that feeds authenticated real-world data into each human’s Digital Twin.

Flourishing AI

Flourishing AI (FAI) is trending as community members speculate on its potential for a massive price recovery, fueled by optimism around its integration with the Base network and broader hype surrounding AI-related crypto tokens. Investors are actively debating whether the project serves as a legitimate under-the-radar utility play or a high-risk gamble, with many tracking technical setups while monitoring volume spikes for signs of an impending breakout.

Direxion Shares ETF Trust - Direxion Daily S&P Oil & Gas Exp. & Prod. Bull 2X ETF

Direxion Daily S&P Oil & Gas Exp. & Prod. Bull 2X Shares

GUSH is trending as investors aggressively debate the volatility of oil and gas exploration stocks amid ongoing Middle East tensions and speculation over potential supply disruptions at the Strait of Hormuz. While some community members view current price action as a buying opportunity based on geopolitical instability, others are skeptical, citing the risk of rapid reversals should diplomatic solutions or production shifts emerge.

Global X Funds - Global X DAX Germany ETF

Global X DAX Germany ETF

The Global X DAX Germany ETF (DAX) is currently trending as traders and analysts utilize Elliott Wave theory to navigate its bullish recovery, with community discussions focusing on high-frequency 'Blue Box' buying zones and the index's resilience amidst shifting geopolitical trade tensions. Sentiment remains heavily influenced by technical roadmap updates, as members track the index's ability to maintain upward momentum and potential breakout targets.

Roundhill ETF Trust - Roundhill Space & Technology ETF

Investors are increasingly turning to space-focused ETFs like MARS to gain broad exposure to the rapidly growing space technology sector, which many in the community view as a long-term thematic trade similar to the rise of artificial intelligence. While some debate the specific benefits of different ETFs based on their individual holdings and exposure to major industry players, the collective sentiment emphasizes these funds as a potentially safer, more accessible alternative to picking individual stocks in an inherently volatile industry.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Achieve Life Sciences Reports Q1 2026 Results: Full Earnings Call Transcript

Achieve Life Sciences (ACHV) to Release Quarterly Earnings on Tuesday

Achieve Life Sciences (NASDAQ:ACHV) will be releasing its Q1 2026 earnings before the market opens on Tuesday, May 12. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2026-5-12-achieve-life-sciences-inc-stock...

Achieve Life Sciences (NASDAQ:ACHV) Stock Price Passes Above 200 Day Moving Average   - Time to Sell?

Achieve Life Sciences (NASDAQ:ACHV) Stock Price Crosses Above Two Hundred Day Moving Average - Should You Sell...

Achieve Life Sciences, Inc. (NASDAQ:ACHV) Given Average Rating of "Buy" by Brokerages

Achieve Life Sciences, Inc. (NASDAQ:ACHV - Get Free Report) has been assigned an average recommendation of "Buy" from the six ratings firms that are presently covering the firm, Marketbeat reports...

ACHV Stock On Track To For Best Day In Over 7 Years — What’s Driving The Rally?

Equity

Though Achieve Life Sciences expects the FDA to reject its current cytisinicline application for the treatment of nicotine dependence, the company is hopeful of imminent approval following a resubmission in the fourth quarter. 


Achieve Life Sciences' (ACHV) Buy Rating Reiterated at HC Wainwright

HC Wainwright reaffirmed a "buy" rating and set a $12.00 target price on shares of Achieve Life Sciences in a research report on Thursday...

Achieve Life Sciences, Inc. (NASDAQ:ACHV) Receives Average Rating of "Moderate Buy" from Brokerages

Shares of Achieve Life Sciences, Inc. (NASDAQ:ACHV - Get Free Report) have been assigned an average rating of "Moderate Buy" from the five analysts that are presently covering the firm...

What is Zacks Research's Estimate for ACHV FY2026 Earnings?

Achieve Life Sciences, Inc. (NASDAQ:ACHV - Free Report) - Zacks Research dropped their FY2026 earnings per share estimates for shares of Achieve Life Sciences in a note issued to investors on...

HC Wainwright Has Positive Estimate for ACHV FY2026 Earnings

Achieve Life Sciences, Inc. (NASDAQ:ACHV - Free Report) - Equities researchers at HC Wainwright boosted their FY2026 earnings estimates for shares of Achieve Life Sciences in a research report issued...

Achieve Life Sciences Flags FDA Observations While Pushing Launch To 2027 For Smoking Cessation Med

Achieve Life Sciences taps Adare for cytisinicline manufacturing as stock falls; reports wider losses and shifts US launch timeline to 2027.read more...

Achieve Life Sciences, Inc. is a late-stage specialty pharmaceutical company focused on the global development and commercialization of cytisinicline as a treatment of nicotine dependence. Its products include cytisine, a plant-based alkaloid with a binding affinity to the nicotinic acetylcholine receptor. The company was founded in October 1991 and is headquartered in Bothell, WA.

Fiscal Period	Estimated	Reported	Surprise	Result
Q2 '26	-$0.16	--	--	N/A
Q1 '26	-$0.30	-$0.19	36.36%	BEAT
Q4 '25	-$0.29	-$0.28	2.78%	BEAT
Q3 '25	-$0.24	-$0.28	-14.75%	MISSED
Q2 '25	-$0.37	-$0.37	-1.09%	MISSED

ACHV
Achieve Life Sciences Inc.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest Earnings Results: Q1 '26

Historical Earnings

Compact View

Latest ACHV News

ACHVAchieve Life Sciences Inc.